Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

The Faculty of Medicine - Immunology and Cancer Research: Brautbar Chaim


Last updated December 2021 -  Immunology and Cancer Research

List of Publications

(1) Bishara A, Brautbar C, Cereb N, Israel S. Identification of 33 novel HLA alleles in Arab potential bone marrow donors. HLA 2020;95(2):128-130.

(2) Bishara A, Halagan M, Brautbar C, Israel S, Maiers M, Madbouly A. High resolution HLA allele and haplotype frequencies for Arab donors in the Hadassah bone marrow donor registry. Hum Immunol 2019;80(10):823-827.

(3) Aboukaoud M, Israel S, Brautbar C, Eyal S. Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations. Pharm Res 2018;35(11).

(4) Maggio N, Firer M, Zaid H, Bederovsky Y, Aboukaoud M, Gandelman-Marton R, et al. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel. J Clin Pharmacol 2017;57(7):823-829.

(5) Israel S, Maggio N, Ekstein D, Zaid H, Firer M, Bederovsky Y, et al. Genetic risk factors for antiepileptic drug–induced hypersensitivity reactions in Israeli populations. Epilepsia 2016;57(10):e205-e209.

(6) Fernandez Vina MA, Hollenbach JA, Lyke KE, Sztein MB, Maiers M, Klitz W, et al. Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations. Philos Trans R Soc B Biol Sci 2012;367(1590):820-829.

(7) Klitz W, Gragert L, Maiers M, Fernandez-Viña M, Ben-Naeh Y, Benedek G, et al. Genetic differentiation of Jewish populations. Tissue Antigens 2010;76(6):442-458.

(8) Benedek G, Paperna T, Avidan N, Lejbkowicz I, Oksenberg JR, Wang J, et al. Opposing effects of the HLA-DRB10301-DQB10201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel. Genes Immun 2010;11(5):423-431.

(9) Benedek G, Brautbar C, Vardi P, Sharon N, Weintrob N, Zung A, et al. Effect of polymorphism in insulin locus and HLA on type 1 diabetes in four ethnic groups in Israel. Tissue Antigens 2009;73(1):33-38.

(10) Gazit R, Hershko K, Ingbar A, Schlesinger M, Israel S, Brautbar C, et al. Immunological assessment of familial tinea corporis. J Eur Acad Dermatol Venereol 2008;22(7):871-874.

(11) Thomson G, Valdes AM, Noble JA, Kockum I, Grote MN, Najman J, et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: A meta-analysis. Tissue Antigens 2007;70(2):110-127.

(12) Israel S, Weinrib L, Weintrob N, Miller K, Brautbar C. Distribution of the V281L mutation of the CYP21 gene in Israeli congenital adrenal hyperplasia patients and its association with HLA-B14. Pediatr Endocrinol Rev 2006;3(SUPPL. 3):447-450.

(13) Bishara A, Brautbar C, Zamir G, Eid A, Safadi R. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. Hum Immunol 2005;66(11):1099-1105.

(14) De Santis D, Bishara A, Witt CS, Nagler A, Brautbar C, Slavin S, et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens 2005;65(6):519-528.

(15) Martínez-Borra J, Brautbar C, González S, Enk CD, López-Vázquez A, López-Larrea C. The region of 150 kb telometic to HLA-C is associated with psoriasis in the jewish population. J Invest Dermatol 2005;125(5):928-932.

(16) Zung A, Elizur M, Weintrob N, Bistritzer T, Hanukoglu A, Zadik Z, et al. Type 1 diabetes in Jewish Ethiopian immigrants in Israel: HLA class II immunogenetics and contribution of new environment. Hum Immunol 2004;65(12):1463-1468.

(17) Bishara A, De Santis D, Witt CC, Brautbar C, Christiansen FT, Or R, et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 2004;63(3):204-211.

(18) Bishara A, Brautbar C, Eid A, Scherman L, Ilan Y, Safadi R. Is presensitization relevant to liver transplantation outcome? Hum Immunol 2002;63(9):742-750.

(19) Peled N, Amar A, Peled E, Brautbar C, Pillar G. DRB1*1502-DQB1*0601-DQA1*0103 and DRB1*04-DQB1*0302 in Jewish hypersomnolent patients. Sleep Med 2002;3(3):267-270.

(20) Weintrob N, Israel S, Lazar L, Lilos P, Brautbar C, Phillip M, et al. Decreased cortisol secretion in nonclassical 21-hydroxylase deficiency before and during glucocorticoid therapy. J Pediatr Endocrinol Metab 2002;15(7):985-991.

(21) Bishara A, Mohana N, Nagler A, Brautbar C. Mechanisms of interactions between Natural Killer cells and fibroblasts in graft versus host disease. Eur J Immunogenet 2001;28(2):263.

(22) Bishara A, Brautbar C, Eid A, Sherman L, Safadi R. Killer inhibitory receptor mismatching and liver transplantation outcome. Transplant Proc 2001;33(6):2908.

(23) Bishara A, Admon D, Sherman L, Brautbar C. Detection of anti-HLA antibodies by ELISA: Relevance to heart transplantation. Transplant Proc 2001;33(6):2909.

(24) González S, Brautbar C, Martínez-Borra J, López-Vazquez A, Segal R, Blanco-Gelaz MA, et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol 2001;62(6):632-638.

(25) Klitz W, Brautbar C, Schito AM, Barcellos LF, Oksenberg JR. Evolution of the CCR5 δ32 mutation based on haplotype variation in Jewish and Northern European population samples. Hum Immunol 2001;62(5):530-538.

(26) Nagler A, Aker M, Or R, Naparstek E, Varadi G, Brautbar C, et al. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. Exp Hematol 2001;29(3):362-370.

(27) Kwon OJ, Brautbar C, Weintrob N, Sprecher E, Saphirman C, Bloch K, et al. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients. Hum Immunol 2001;62(1):85-91.

(28) Hodak E, Lapidoth M, Kohn Y, David M, Brautbar C, Kfir B, et al. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients. Br J Dermatol 2001;145(6):974-980.

(29) Weintrob N, Sprecher E, Israel S, Pinhas-Hamiel O, Kwon OJ, Bloch K, et al. Type 1 diabetes environmental factors and correspondence analysis of HLA class II genes in the Yemenite Jewish community in Israel. Diabetes Care 2001;24(4):650-653.

(30) Israel S, Brautbar C. A molecular method of diagnosi of Congenital Adrenal Hyperplasia. Harefuah 2000;139(11-12):429-433.

(31) Tsafrir A, Brautbar C, Nagler A, Elchalal U, Miller K, Bishara A. Alloreactivity of umbilical cord blood mononuclear cells: Specific hyporesponse to noninherited maternal antigens. Hum Immunol 2000;61(6):548-554.

(32) Meir MB, Hadas-Halperin I, Fisher D, Rosenmann E, Brautbar C, Branski D, et al. Neonatal sclerosing cholangitis associated with autoimmune phenomena. J Pediatr Gastroenterol Nutr 2000;30(3):332-334.

(33) Levy J, Amar A, Brautbar C, Slavin S, Kapelushnik J. Transient recovery of endogenous immune function following haploidentical peripheral stem cell transplantation in a patient with severe combined immunodeficiency without evidence of engraftment. Acta Paediatr Int J Paediatr 2000;89(2):248-250.

(34) Elchalal U, Fasouliotis SJ, Shtockheim D, Brautbar C, Schenker JG, Weinstein D, et al. Postpartum umbilical cord blood collection for transplantation: A comparison of three methods. Am J Obstet Gynecol 2000;182(1 I):227-232.

(35) Weintrob N, Brautbar C, Pertzelan A, Josefsberg Z, Dickerman Z, Kauschansky A, et al. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency. Eur J Endocrinol 2000;143(3):397-403.

(36) Hurley CK, Wade JA, Oudshoorn M, Middleton D, Kukuruga D, Navarrete C, et al. A special report: Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Tissue Antigens 1999;53(4 I):394-406.

(37) Mora B, Battat S, Grillo R, Safirman C, Israel S, Brautbar C, et al. Strong linkage disequilibrium of TAP1*0301 and TAP2D alleles with the HLA A1-B35-DRB1*1104-DQA1*0103-DQB1*0603 extended haplotype in Ashkenazi Jews. Eur J Immunogenet 1999;26(5):331-335.

(38) Bishara A, Brautbar C, Cohen I, Nagler A. Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome. Hum Immunol 1999;60(9):833-839.

(39) Amar A, Kwon OJ, Motro U, Witt CS, Bonne-Tamir B, Gabison R, et al. Molecular analysis of HLA class II polymorphisms among different ethnic groups in Israel. Hum Immunol 1999;60(8):723-730.

(40) Naparstek E, Delukina M, Or R, Nagler A, Kapelushnik J, Varadi G, et al. Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies. Exp Hematol 1999;27(7):1210-1218.

(41) Bishara A, Sherman L, Freidlander M, Eid A, Brautbar C. Comparison of ELISA QuickScreen and PRA-STAT with CDC-AHG for PRA determination. Transplant Proc 1999;31(4):1878.

(42) Bishara A, Sherman L, Raizman S, Popovtzer M, Brautbar C. Negative response to noninherited maternal antigens confirmed by ELISA. Transplant Proc 1999;31(4):1879-1880.

(43) Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, Sanchez Del Río J, Rodriguez Pérez A, et al. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 1999;42(5):1010-1016.

(44) Karni A, Kohn Y, Safirman C, Abramsky O, Barcellos L, Oksenberg JR, et al. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel. Mult Scler 1999;5(6):410-415.

(45) Varadi G, Or R, Kapelushnik J, Naparstek E, Nagler A, Brautbar C, et al. Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma. Leuk Lymphoma 1999;34(1-2):185-190.

(46) Shai R, Quismorio Jr. FP, Li L, Kwon O-, Morrison J, Wallace DJ, et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 1999;8(4):639-644.

(47) Hurley CK, Wade JA, Oudshoorn M, Middleton D, Kukuruga D, Navarrete C, et al. A special report: Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Hum Immunol 1999;60(4):347-360.

(48) Amar A, Brautbar C, Motro U, Fisher T, Bonne-Tamir B, Israel S. Genetic variation of three tetrameric tandem repeats in four distinct Israeli ethnic groups. J Forensic Sci 1999;44(5):983-986.

(49) Hurley CK, Wade JA, Oudshoorn M, Middleton D, Kukuruga D, Navarrete C, et al. Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: Report from The World Marrow Donor Association. Bone Marrow Transplant 1999;24(2):119-121.

(50) Kwon OJ, Karni A, Israel S, Brautbar C, Amar A, Meiner Z, et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol 1999;56(5):555-560.

(51) Shinar Y, Pras E, Siev-Ner I, Gamus D, Brautbar C, Israel S, et al. Analysis of allelic association between D6S461 marker and multiple sclerosis in Ashkenazi and Iraqi Jewish patients. J Mol Neurosci 1998;11(3):265-269.

(52) Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, et al. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med 1998;105(6):484-487.

(53) Israel S, Kwon OJ, Weintrob N, Sprecher E, Bloch K, Assa S, et al. Hla class II immunogenetics of IDDM in Yemenite Jews. Hum Immunol 1998;59(11):728-733.

(54) Nagler A, Bishara A, Brautbar C, Barak V. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation. Cytokines Cell Mol Ther 1998;4(3):161-167.

(55) Frucht-Pery J, Siganos CS, Solomon A, Scheman L, Brautbar C, Zauberman H. Limbal cell autograft transplantation for severe ocular surface disorders. Graefe's Arch Clin Exp Ophthalmol 1998;236(8):582-587.

(56) Bishara A, Aker M, Amar A, Brautbar C, Schlesinger M, Rabinowitz R, et al. Enhanced lymphoid cell recovery after bone marrow transplantation: Correlation with the presence of costimulatory antibodies in serum. Exp Hematol 1998;26(7):580-587.

(57) Bishara A, Malka R, Brautbar C, Barak V, Cohen I, Kedar E. Cytokine production in human mixed leukocyte reactions performed in serum-free media. J Immunol Methods 1998;215(1-2):187-190.

(58) Mehrian R, Quismorio Jr. FP, Strassmann G, Stimmler MM, Horwitz DA, Kitridou RC, et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 1998;41(4):596-602.

(59) Bishara A, Nagler A, Brautbar C. Cellular test used to determine compatibility between bone marrow donor and recipient in HLA in identical twins. Harefuah 1998;134(6):471-476.

(60) Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998;91(3):756-763.

(61) Kauschansky A, Frydman M, Assa S, Kwon OJ, Israel S, Lazard D, et al. D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: A lesson from patients with Wilson's disease. Clin Immunol Immunopathol 1998;89(3):279-283.

(62) Freier S, Kerem E, Dranitzki Z, Schlesinger M, Rabinowitz R, Brautbar C, et al. Hereditary CD4+ T lymphocytopenia. Arch Dis Child 1998;78(4):371-372.

(63) Or R, Ackerstein A, Nagler A, Amar A, Naparstek E, Varadi G, et al. Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation. J Immunother 1998;21(6):447-453.

(64) Amar A, Segman RH, Shtrussberg S, Sherman L, Safirman C, Lerer B, et al. An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201. Int J Neuropsychopharmacol 1998;1(1):41-44.

(65) Frucht-Pery J, Siganos CS, Solomon A, Brautbar C, Zauberman H. Conjunctival limbal cell transplantation [clct] for ocular surface disorders. Invest Ophthalmol Vis Sci 1997;38(4).

(66) Bishara A, Brautbar C, Cohen J, Naglar A. Prediction of transplant related complications post unrelated bone marrow transplantation (bmt) by modified mixed leukocyte culture (mlr) assay. Exp Hematol 1997;25(8):823.

(67) Del Carmen Theiler G, Vilches C, Battat S, Brautbar C, Gebuhrer L, Papasteriades C, et al. HLA-B35 alleles in 282 individuals from nine different populations of Europe and Israel. Immunogenetics 1997;46(6):524-528.

(68) Bishara A, Sherman L, Brautbar C, Claas F, Friedlander M, Rubinger D, et al. Pretransplant crossmatching: An individualized process. Transplant Proc 1997;29(6):2708-2710.

(69) Bishara A, Brautbar C, Nagler A. HLA and graft-versus-host disease: A population-based study of HLA phenotypes of Jewish and Arabic bone marrow transplanted patients in Israel. Leuk Res 1997;21(2):111-118.

(70) Karni A, Zisman E, Katz-Levy Y, Paas-Rozner M, Dayan M, Brautbar C, et al. Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor. Neurology 1997;48(6):1638-1642.

(71) Israel S, Smith AG, Miller K, Marashi A, Hansen JA, Brautbar C. Two new DR2 alleles: DRB1*1607 identified in an Ashkenazi Jewish family and DRB1*15022 found in a single Caucasian donor. Tissue Antigens 1997;49(2):173-175.

(72) Yinnon AM, Rudensky B, Sagi E, Breuer G, Brautbar C, Polacheck I, et al. Invasive cryptococcosis in a family with epidermodysplasia verruciformis and idiopathic CD4 cell depletion. Clin Infect Dis 1997;25(5):1252-1253.

(73) Nagler A, Brautbar C, Slavin S, Bishara A. Bone marrow transplantation using unrelated and family related donors: The impact of HLA-C disparity. Bone Marrow Transplant 1996;18(5):891-897.

(74) Friedlaender MM, Azem O, Rubinger D, Brautbar C. Effect of human recombinant erythropoietin therapy on panel reactive antibodies in chronic dialysis patients. Isr J Med Sci 1996;32(9):730-736.

(75) Zisman E, Katz-Levy Y, Dayan M, Kirshner SL, Paas-Rozner M, Karni A, et al. Peptide analogs to pathogenic epitopes of the human acetylcholine receptor a subunit as potential modulators of myasthenia gravis. Proc Natl Acad Sci U S A 1996;93(9):4492-4497.

(76) Slavin S, Naparstek E, Nagler A, Ackerstein A, Samuel S, Kapelushnik J, et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996;87(6):2195-2204.

(77) Bishara A, Brautbar C, Nagler A. Interaction between natural killer (NK) cells and the major histocompatibility system. Harefuah 1996;130(5):322-326.

(78) Bishara A, Amar A, Brautbar C, Condiotti R, Lazarovitz V, Nagler A. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Exp Hematol 1995;23(14):1667-1675.

(79) Frisan T, Sjöberg J, Dolcetti R, Boiocchi M, De Re V, Carbone A, et al. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 1995;86(4):1493-1501.

(80) Elchalal U, Shushan A, Brautbar C, Peleg D, Vardi G, Schenker JG, et al. Human umbilical cord blood as a source of hematopoietic progenitor cells for transplantations. Harefuah 1995;128(12):776-780.

(81) Gofrit O, Eid A, Friedlander M, Rubinger D, Brautbar C, Shiloni E, et al. Kidney transplantation from living, related donors. Harefuah 1995;128(4):201-204, 264.

(82) Varadi G, Elchalal U, Brautbar C, Nagler A. Human umbilical cord blood for hematopoietic progenitor cells transplantation. Leuk Lymphoma 1995;20(1-2):51-58.

(83) Kwon OJ, Peled N, Miller K, Pillar G, Peled R, Lavie P, et al. HLA class II analysis in Jewish Israeli narcoleptic patients. Hum Immunol 1995;44(4):199-202.

(84) Zisman E, Brautbar C, Sela M, Abramsky O, Battat S, Kirshner SL, et al. Binding of peptides of the human acetylcholine receptor α-subunit to HLA class II of patients with myasthenia gravis. Hum Immunol 1995;44(3):121-130.

(85) Vardy DA, Klapholz L, Brautbar C, Tambur AR, Pisanty S, Rosenmann E, et al. Castleman's disease associated pemphigus. A form of paraneoplastic pemphigus. J Eur Acad Dermatol Venereol 1995;4(3):273-279.

(86) Rave-Harel N, Madgar I, Goshen R, Nissim-Rafinia M, Ziadni A, Rahat A, et al. CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am J Hum Genet 1995;56(6):1359-1366.

(87) Roitberg‐Tambur A, Witt CS, Friedmann A, Safirman C, Sherman L, Battat S, et al. Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens 1995;46(2):104-110.

(88) Evron E, Brautbar C, Becker S, Fenakel G, Abend Y, Sthoeger Z, et al. Correlation between gold‐induced enterocolitis and the presence of the HLA‐DRB 1*0404 allele. Arthritis Rheum 1995;38(6):755-759.

(89) Naparstek E, Or R, Nagler A, Cividalli G, Engelhard D, Aker M, et al. T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse. Br J Haematol 1995;89(3):506-515.

(90) Matzner Y, Erlich HA, Brautbar C, Sanilevitch A, Landau M, Brenner S, et al. Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris. ACTA DERM -VENEREOL 1995;75(1):12-14.

(91) Lewin N, Avila‐Cariño J, Minarovits J, Lennette E, Brautbar C, Mellstedt H, et al. Detection of two epstein‐barr‐virus (EBV)‐carrying leukemic cell clones in a patient with chronic lymphocytic leukemia (CLL). Int J Cancer 1995;61(2):159-164.

(92) Engelhard D, Elishoov H, Or R, Naparstek E, Nagler A, Strauss N, et al. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: A 5-year prospective study. Bone Marrow Transplant 1995;16(4):565-570.

(93) Brautbar C, Safirman C, Roitberg-Tambur A. HLA polymorphism at the molecular level and its role in organ and bone marrow transplantation. Harefuah 1994;126(12):737-742.

(94) Fridkis-Hareli M, Teitelbaum D, Gurevich E, Pecht I, Brautbar C, Oh Joong Kwon, et al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells-specificity and promiscuity. Proc Natl Acad Sci U S A 1994;91(11):4872-4876.

(95) Segal R, Elkayam O, Caspi D, Brautbar C, Yaron M. Familial presentation of Early osteoarthritis with a HLA-DR association. Clin Rheumatol 1994;13(1):139-141.

(96) Nagler A, Naparstek E, Drakos P, Brautbar C, Goldman M, Kaplan O, et al. Interleukin-3 in combination with granulocyte-macrophage-colony-stimulating factor following bone marrow transplantation in a radiation accident victim. Med Oncol 1994;11(1):27-28.

(97) Shapira L, Smidt A, Van Dyke TE, Barak V, Soskolne AW, Brautbar C, et al. Sequential manifestation of different forms of early-onset periodontitis. A case report. J Periodontol 1994;65(6):631-635.

(98) Roitberg-Tambur A, Friedmann A, Witt CS, Eisenberg S, Aubrey Soskolne W, Shapira L, et al. HLA polymorphism in Moroccan Jewry. Hum Immunol 1994;40(1):61-67.

(99) Bishara A, Brautbar C, Nagler A, Slavin S, Leshem B, Cohen I, et al. Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation. Transplantation 1994;57(10):1474.

(100) Smith AG, Safirman C, Kelso C, Amar A, Hansen JA, Brautbar C. Two new DR52‐associated alleles, DRB1*1111 and *1312, identified by PCR/SSOP and confirmed by DNA sequencing. Tissue Antigens 1994;44(1):52-56.

(101) Roitberg-Tambur A, Friedmann A, Tzfoni EE, Battat S, Hammo RB, Safirman C, et al. Do specific pockets of HLA-C molecules predispose Jewish patients to psoriasis vulgaris? J Am Acad Dermatol 1994;31(6):964-968.

(102) González-Roces S, Brautbar C, Peña M, Dominguez O, Coto E, Alvarez V, et al. Molecular analysis of HLA-B27 haplotypes in caucasoids frequencies of B27-Cw in jewish and spanish populations. Hum Immunol 1994;41(2):127-134.

(103) Amar A, Battat S, Anteby SO, Brautbar C, Reubinoff BE. INVASIVE SQUAMOUS CELL CARCINOMA OF THE CERVIX: IS HLA‐DQ A DISEASE MARKER IN JEWISH PATIENTS? Int J Immunogenet 1993;20(5):327-333.

(104) Friedmann A, Brautbar C. Immune response genes and autoimmune diseases. Isr J Med Sci 1993;29(2-3):145-150.

(105) Eilam O, Goldin E, Shouval D, Gimon T, Brautbar C. Sclerosing cholangitis associated with Crohn's disease and autoimmune haemolytic anaemia. Postgrad Med J 1993;69(814):656-658.

(106) Roitberg-Tambur A, Friedmann A, Safirman C, Markitziu A, Ben-Chetrit E, Rubinow A, et al. Molecular analysis of HLA class II genes in primary sjögren's syndrome. A study of Israeli Jewish and Greek Non-Jewish patients. Hum Immunol 1993;36(4):235-242.

(107) Bishara A, Kedar E, Leshem B, Slavin S, Cohen I, Brautbar C. A 2‐DAY MLR PROCEDURE FOR MARROW DONOR SELECTION FOR ALLOGENEIC BONE MARROW TRANSPLANTATION. Int J Immunogenet 1993;20(4):289-292.

(108) Amar A, Brautbar C, Goldin E, Sherman L, Barmeir S, Shouval D, et al. SEROLOGICAL AND MOLECULAR ANALYSIS OF HLA IN ISRAELI PRIMARY SCLEROSING CHOLANGITIS PATIENTS. Int J Immunogenet 1992;19(5):295-302.

(109) Meiner Z, Zlotogorski A, Brautbar C. Pemphigus associated with multiple sclerosis. Clin Exp Dermatol 1992;17(3):217-217.

(110) Friedlaender MM, Avitzor M, Ayalon A, Berlatzki Y, Brautbar C, Darmon D, et al. Kidney transplantation in Jerusalem, 1972-89. Isr J Med Sci 1992;28(1):1-8.

(111) Foldes J, Shamir S, Brautbar C, Schermann L, Menczel J. HLA-D antigens and Paget's disease of bone. CLIN ORTHOP RELAT RES 1991;266:301-303.

(112) Elkayam O, Caspi D, Segal R, Brautbar C, Ben‐Chetrit E, Yaron M. Familial Erythema Nodosum. Arthritis Rheum 1991;34(9):1177-1179.

(113) Fernandez-Viña MA, Gao X, Moraes ME, Moraes JR, Salatiel I, Miller S, et al. Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics 1991;34(5):299-312.

(114) Gao X, Stastny P, Brautbar C, Naparstek Y, Gazit E, Livneh A, et al. A variant of HLA–DR4 determines susceptibility to rheumatoid arthritis in a subset of Israeli Jews. Arthritis Rheum 1991;34(5):547-551.

(115) Elkayam O, Zinger H, Zisman E, Segal R, Yaron M, Brautbar C, et al. Regulatory T cell activity specific to human type II and III collagens in rheumatoid arthritis. J Rheumatol 1991;18(4):516-521.

(116) Bishara A, Kedar E, Leshem B, Rosenkovitch E, Brautbar C. A short human and mouse mlr assay utilizing lymphokine (Il-2, il-3) secretion as an early activation event. Transplantation 1991;51(5):1104-1109.

(117) Roitberg-Tambur A, Brautbar C, Markitziu A, Ben-Chetrit E, Rubinow A, Friedmann A. Immunogenetics of HLA class II genes in primary Sjogren's syndrome in Israeli Jewish patients. Isr J Med Sci 1990;26(12):677-681.

(118) Bishara A, Brautbar C. Detection and identification of HLA antigens in dried spleens by means of enzyme linked immunosorbent assay (ELISA). Forensic Sci Int 1990;45(1-2):97-105.

(119) Zlotogorski A, Weinrauch L, Brautbar C. Familial alopecia areata: No linkage with HLA. Tissue Antigens 1990;36(1):40-41.

(120) Bishara A, Sharon R, Kohn G, Nelken D, Brautbar C. Determination of surface bound and shed HLA antigens of amniotic cells by ELISA. Isr J Med Sci 1990;26(1):34-38.

(121) Scharf SJ, Freidmann A, Steinman L, Brautbar C, Erlich HA. Erratum: Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris (Proc. Natl. Acad. Sci. USA (86, 6215-6219)). Proc Natl Acad Sci U S A 1989;86(24):10023.

(122) Bishara A, Brautbar C. A sensitive and specific ELISA using monoclonal capture antibodies for the detection of HLA antigens in blood stains. J Immunol Methods 1989;120(1):99-103.

(123) Tzfoni E, Brautbar C, Friedman A. Pemphigus vulgaris immunogenetics. J Am Acad Dermatol 1989;21(3):594.

(124) Slavin S, Naparstek E, Aker M, Cividalli G, Engelhard D, Hardan Y, et al. The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders. Transplant Proc 1989;21(1 III):3053-3054.

(125) Scharf SJ, Freidmann A, Steinman L, Brautbar C, Erlich HA. Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris. Proc Natl Acad Sci U S A 1989;86(16):6215-6219.

(126) Or R, Naparstek E, Aker M, Cividalli G, Engelhard D, Brautbar C, et al. Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major. Prog Clin Biol Res 1989;309:217-222.

(127) Segal R, Dayan M, Epstein N, Zecler E, Peller S, Michalevitch R, et al. Common variable immunodeficiency: A family study and therapeutic trial with cimetidine. J Allergy Clin Immunol 1989;84(5 PART 1):753-761.

(128) Leshem B, Cohen I, Sherman L, Brautbar C, Kedar E. Typing of HLA class II and class I antigens using PHA-activated, IL-2-propagated T lymphocytes. J Immunol Methods 1988;111(1):131-135.

(129) Bishara SA, Bishara AH, Brautbar C. Zonal variation of HLA expression on human cornea epithelium. Cornea 1988;7(4):252-256.

(130) Brocke S, Brautbar C, Steinman L, Abramsky O, Rothbard J, Neumann D, et al. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patient with myasthenia gravis and relation to HLA class II genes. J Clin Invest 1988;82(6):1894-1900.

(131) Sinha AA, Brautbar C, Szafer F, Friedmann A, Tzfoni E, Todd JA, et al. A newly characterized HLA DQβ allele associated with pemphigus vulgaris. Science 1988;239(4843):1026-1029.

(132) Bishara A, Nelken D, Brautbar C. Differential Expression of HLA Class-I Antigens on B and T Lymphocytes Obtained from Human Lymphoid Tissues. Immunobiology 1988;177(1):76-81.

(133) Torsteinsdottir S, Brautbar C, Klein G, Klein E, Masucci MG. Differential expression of hla antigen of HLA anigens on human B‐cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells? Int J Cancer 1988;41(6):913-919.

(134) Friedlaender MM, Rubinger D, Popovitzer MM, Berlatski Y, Silver J, Brautbar C. Successful HLA-A, B, C, DR and DQ-identical sibling kidney transplantation with mixed lymphocyte culture reactivity and positive B-cell cross-match. Isr J Med Sci 1988;24(2):119-122.

(135) Amar A, Zohar M, Tiwari J, Brautbar C. HLA and schizophrenia in Israel. Isr J Med Sci 1988;24(1):28-31.

(136) Tomer Y, Zamir R, Brautbar C, Pinkhas J, Weinberger A. HLA antigens in patients with Heberden's nodes. Isr J Med Sci 1988;24(1):24-27.

(137) Wilner A, Steinman L, Lavie P, Peled R, Friedmann A, Brautbar C. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype A study at the serological and genomic level. Hum Immunol 1988;21(1):15-22.

(138) Slavin S, Or R, Cividalli G, Brautbar C, Hale G, Waldmann H, et al. Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease. Birth Defects Orig Artic Ser 1988;23(5 B):313-316.

(139) OKSENBERG JR, MOR‐YOSEF S, EZRA Y, BRAUTBAR C. Antigen Presenting Cells in Human Decidual Tissue: III. Role of Accessory Cells in the Activation of Suppressor Cells. Am J Reprod Immunol Microbiol 1988;16(4):151-158.

(140) Mozes E, Mendlovic S, Bentwich Z, Brautbar C, Shoenfeld Y. T-cell-helper factors in autoimmunity. Isr J Med Sci 1988;24(7):355-358.

(141) Scharf SJ, Friedmann A, Brautbar C, Szafer F, Steinman L, Horn G, et al. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci U S A 1988;85(10):3504-3508.

(142) Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci U S A 1987;84(13):4567-4571.

(143) Milwidsky A, Hurwitz A, Nubani N, Palti Z, Adoni A, Brautbar C. Absence of HLA linkage in familial hypogonadotropic hypogonadism. J REPROD MED OBSTET GYNECOL 1987;32(2):96-98.

(144) Chajek-Shaul T, Pisanty S, Knobler H, Matzner Y, Glick M, Ron N, et al. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behcet's syndrome. Am J Med 1987;83(4):666-672.

(145) Tishler M, Brautbar C, Battat S, Dayan M, Mozes E. Analysis of the antigen specific helper T cell function and HLA‐DR of Israeli patients with rheumatoid arthritis (RA). Tissue Antigens 1987;30(5):229-234.

(146) Katz J, Goultschin J, Benoliel R, Brautbar C. Human leukocyte antigen (HLA) DR4. Positive association with rapidly progressing periodontitis. J Periodontol 1987;58(9):607-610.

(147) Cohen N, Mickelson E, Amar A, Battat S, Hansen JA, Brautbar C. HLA-Dw clusters associated with DR4 in Israeli Jews and the definition of a new DR4 associated Dw subtype: Dw"SHA". Hum Immunol 1987;19(3):179-188.

(148) BISHARA A, OKSENBERG JR, FRANKEL G, MARGALIOTH EIJ, PERSITZ E, NELKEN D, et al. Human Leukocyte Antigens (HLA) Class I and Class II on Sperm Cells Studied at the Serological, Cellular, and Genomic Levels. Am J Reprod Immunol Microbiol 1987;13(4):97-103.

(149) Zeliszewski D, Sterkers G, Brautbar C, Betuel H, Layrisse Z, Levy JP. Functional relationships between HLA-DR2-short/FJO, DB9, and AZH as defined by DR- and DQ-restricted influenza-specific cloned T cells. Immunogenetics 1987;26(1-2):107-110.

(150) Szafer F, Brautbar C, Tzfoni E, Frankel G, Sherman L, Cohen I, et al. Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region. Proc Natl Acad Sci U S A 1987;84(18):6542-6545.

(151) Torsteinsdottir S, Masucci MG, Ehlin-Henriksson B, Brautbar C, Ben Bassat H, Klein G, et al. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc Natl Acad Sci U S A 1986;83(15):5620-5624.

(152) Brautbar C, Mukamel M, Yaron M, Naparstek Y, Korman SH, Amar A, et al. Immunogenetics of juvenile chronic arthritis in Israel. J Rheumatol 1986;13(6):1072-1075.

(153) Tishler M, Brautbar C, Yaron M, Dayan M, Mozes E. Association between HLA-DR4 and production of collagen-specific antibodies in Israeli patients with rheumatoid arthritis. Isr J Med Sci 1986;22(11):771-773.

(154) Segal R, Brautbar C, Katz D, Shalev Y, Bentwich Z, Mozes E. Analysis of antigen specific T cell helper function in the first degree relatives of patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1986;66(1):52-60.

(155) Shalev Y, Bentwich Z, Katz D, Brautbar C, Mozes E. Antigen specific immune response potential and HLA typing of Israeli patients with thyroid autoimmune diseases (TAD). Clin Exp Immunol 1986;64(2):255-260.

(156) Cohen N, Friedmann A, Szafer F, Amar A, Cohen D, Brautbar C. Polymorphism of the HLA DR1 haplotype in the Israeli population investigated at the serological, cellular, and genomic levels. Immunogenetics 1986;23(4):252-259.

(157) Torsteinsdottir S, Masucci MG, Brautbar C, Lenoir G, Klein G, Klein E. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones. Cell Immunol 1986;98(2):453-466.

(158) Cohen N, Brautbar C, Font M-, Dausset J, Cohen D. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics 1986;23(2):84-89.

(159) Katz D, Suez D, Brautbar C, Cohen T, Bentwich Z, Mozes E. Genetic control of HLA-linked immune responsiveness to (H,G)-AL. Hum Immunol 1986;15(1):75-84.

(160) Persitz E, Oksenberg J, Brautbar C. The HLA system and habitual spontaneous abortions. Harefuah 1986;110(1):33-36.

(161) OKSENBERG JR, MOR‐YOSEF S, PERSITZ E, SCHENKER Y, MOZES E, BRAUTBAR C. Antigen‐Presenting Cells in Human Decidual Tissue. Am J Reprod Immunol Microbiol 1986;11(3):82-88.

(162) Brautbar C, Naparstek Y, Yaron M, Amar A, Ehrenfeld M, Eliakim M, et al. Immunogenetics of rheumatoid arthritis in Israel. Tissue Antigens 1986;28(1):8-14.

(163) OKSENBERG JR, BRAUTBAR C. In Vitro Suppression of Murine Blastocysts Growth by Sera From Women With Reproductive Disorders. Am J Reprod Immunol Microbiol 1986;11(4):118-124.

(164) Ben-Chetrit E, Brautbar C, Rubinow A. HLA antigens in Reiter's syndrome in Israeli patients. J Rheumatol 1985;12(5):964-966.

(165) Shalev Y, Bentwich Z, Katz D, Brautbar C, Mozes E. (T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus. Clin Exp Immunol 1985;60(2):355-362.

(166) OKSENBERG JR, PERSITZ E, BRAUTBAR C. Cellular Immunity in Human Milk. Am J Reprod Immunol Microbiol 1985;8(4):125-129.

(167) Hurwitz A, Brautbar C, Milwidsky A, Vecsei P, Milewicz A, Navot D, et al. Combined 21- and 11β-hydroxylase deficiency in familial congenital adrenal hyperplasia. J Clin Endocrinol Metab 1985;60(4):631-638.

(168) Suez D, Katz D, Brautbar C, Cohen T, Weisman Z, Bentwich Z, et al. HLA-linked immune responsiveness to (T,G)-A-L: A family study. Hum Immunol 1985;13(4):219-234.

(169) Persitz E, Oksenberg JR, Margalioth EJ, Hacohen S, Schenker J, Brautbar C. Histoincompatibility in couples with unexplained infertility. Fertil Steril 1985;43(5):733-738.

(170) Slavin S, Or R, Weiss L, Steiner-Zalz D, Cividalli G, Brautbar C, et al. Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1. Adv Exp Med Biol 1985;186:813-818.

(171) Karp M, Kott E, Shapira M, Assa S, Brautbar C, Gurewitz R, et al. Unusual association of insulin-dependent diabetes mellitus with congenital myasthenia gravis and autoimmune thyroid disease. Isr J Med Sci 1984;20(11):1078-1081.

(172) Torsteinsdottir S, Masucci MG, Szigeti R, Bishara A, Brautbar C, Klein G, et al. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts. Mol Biol Med 1984;2(4):285-299.


(174) Friedlaender MM, Rubinger D, Silver J, Brautbar C, Durst AL, Czaczkes JW, et al. Ethnic differences in kidney graft survival. Isr J Med Sci 1984;20(3):186-190.

(175) Oksenberg JR, Persitz E, Amar A, Schenker J, Segal S, Nelken D, et al. Mixed lymphocyte reactivity nonresponsiveness in couples with multiple spontaneous abortions. Obstet Gynecol Surv 1984;39(3):165-167.

(176) Amar A, Mickelson E, Hansen JA, Shalev Y, Brautbar C. HLA-Dw"SHY": A new lymphocyte defined specificity associated with HLA-DRw10. Hum Immunol 1984;11(3):143-149.

(177) Amar A, Rubinstein N, Cohen O, Hacham‐Zadeh S, Cohen T, Brautbar C. HLA determinants in psoriasis vulgaris in Israel. Tissue Antigens 1984;24(4):247-249.

(178) Levene C, Steinberg AG, Friedlander Y, Brautbar C, Cohen T. Genetic polymorphisms among Bukharan and Georgian Jews in Israel. Am J Med Genet 1984;19(4):623-641.

(179) Dahan S, Slater PE, Cooper M, Brautbar C, Ashkenazi A. Coeliac disease in the Rehovot-Ashdod region of Israel: Incidence and ethnic distribution. J Epidemiol Community Health 1984;38(1):58-60.

(180) AMAR A, RUBINSTEIN N, HACHAM‐ZADEH S, COHEN O, COHEN T, BRAUTBAR C. Is predisposition to pemphigus vulgaris in Jewish patients mediated by HLA‐Dw10 and DR4? Tissue Antigens 1984;23(1):17-22.

(181) BRAUTBAR C, ZLOTOGORA J, LAUFER N, COHEN T, ALBERT ED. Do identical HLA‐DR3 genes convey susceptibility to celiac disease and insulin dependent diabetes mellitus? Tissue Antigens 1984;23(1):58-60.

(182) BISHARA A, NELKEN D, BONAVIDA B, BRAUTBAR C. Enzyme‐linked immunosorbent assay for determination of HLA: gene dose effect. Tissue Antigens 1984;23(5):284-289.

(183) Oksenberg JR, Persitz E, Amar A, Brautbar C. Maternal-paternal histocompatibility: Lack of association with habitual abortions. Fertil Steril 1984;42(3):389-395.

(184) Cohen N, Amar A, Oksenberg JR, Brautbar C. HLA‐D clusters associated with DR2 and the definition of HLA‐D“AZH”: a new DR2 related HLA‐D specificity in Israel. Tissue Antigens 1984;24(1):1-9.

(185) Mickelson E, Brautbar C, Nisperos B, Cohen N, Amar A, Kim SJ, et al. HLA‐DR2 and DR4 further defined by two new HLA‐D specificities (HTC) derived from Israeli Jewish donors: comparative study in Caucasian, Korean, Eskimo and Israeli populations. Tissue Antigens 1984;24(3):197-205.

(186) Cohen N, Amar A, Brautbar C. Definition of a new DR2 short associated HLA‐D specificity with the Ninth Histocompatibility Workshop reagents. Tissue Antigens 1984;24(3):184-186.

(187) Schlesinger M, Ilfeld DN, Zamir R, Brautbar C. Familial Mediterranean fever: no linkage with HLA. Tissue Antigens 1984;24(1):65-66.

(188) Cohen N, Shaw S, Amar A, Oksenberg J, Brautbar C. HLA‐linked SB antigens in Israel: Population study, analysis of homozygous typing cells and generation of local SB reagents. Tissue Antigens 1984;24(2):113-120.

(189) Naparstek Y, Abrahamov A, Cohen T, Brautbar C. Familial hereditary thrombocytopenia and HLA. Am J Hematol 1984;17(2):113-116.

(190) Bishara A, Brautbar C, Marbach A, Bonavida B, Nelken D. Enzyme-linked immunosorbent assay for HLA determination on fresh and dried lymphocytes. J Immunol Methods 1983;62(2):265-271.

(191) Naparstek E, Amar A, Brautbar C. Suppression of mixed lymphocyte reactivity by cellular and humoral factors in aplastic anemia―both before and after bone marrow transplantation. Transplantation 1983;36(4):365-369.

(192) Wernet P, Shaw S, Brautbar C, Westphal E, Pawelec G. SB Types of HLA-D homozygous typing cells. Immunogenetics 1983;18(5):547-551.

(193) Katz D, Brautbar C, Bentwich Z, Mozes E. Genetically regulated human (T,G)-AL specific helper T cell replacing factors possess HLA-DR and Vh determinants. Hum Immunol 1983;7(4):217-227.

(194) Plesser YM, Markson Y, Weiss DW, Brautbar C, Doljanski F. Shedding of histocompatibility and blood group antigenic determinants from human epithelial cells and fibroblasts in culture. Cell Mol Biol 1983;29(3):227-236.

(195) Brautbar C, Yehuda O, Eisenberg S, Cohen N, Amar A, Sharon R, et al. Study of a family with Cerebrotendinous Xanthomatosis: No HLA linkage, but an informative recombination between HLA—B and Bf. Tissue Antigens 1983;21(3):233-237.

(196) Oksenberg J, Amar A, Cohen N, Grosse‐Wilde H, Cohen I, Sharon R, et al. HLA‐D “BG” in Israel: A Japanese related allele population and family study. Tissue Antigens 1983;21(4):271-280.

(197) Granat M, Amar A, Mor-Yosef S, Brautbar C, Schenker JG. Familial gonadal germinative failure: Endocrine and human leukocyte antigen studies. Fertil Steril 1983;40(2):215-219.

(198) Oksenberg JR, Persitz E, Amar A, Schenker J, Segal S, Nelken D, et al. Mixed lymphocyte reactivity nonresponsiveness in couples with multiple spontaneous abortions. Fertil Steril 1983;39(4):525-529.

(199) Persitz E, Oksenberg J, Amar A, Margalioth EJ, Cohen O, Brautbar C. Histocompatibility antigens, mixed lymphocyte reactivity and severe preeclampsia in Israel. Gynecol Obstet Invest 1983;16(5):283-291.

(200) Levo Y, Tur-Kaspa R, Shouval D, Brautbar C, Eliakim M. Histocompatibility antigens and cell-mediated immunity in carriers of hepatitis B virus; A study of a family. J Clin Lab Immunol 1982;9(2):105-107.

(201) Brautbar C, Amar A, Cohen I, Kahana E, Bloch D, Grosse-Wilde H, et al. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis. Isr J Med Sci 1982;18(5):631-634.

(202) Strehler BL, Abraham S, Bayreuther K, Bienenstock A, Binstock R, Birren J, et al. Hayflick-NIH settlement [3]. Science 1982;215(4530):240-242.

(203) Oksenberg JR, Amar A, Cohen N, Cohen T, Brautbar C. HLA-DR,D recombination in a kidney transplant recipient. Hum Immunol 1982;4(1):47-53.

(204) Brautbar C, Amar A, Cohen N, Oksenberg J, Cohen I, Kahana E, et al. HLA‐D typing in multiple sclerosis: Israelis tested with European homozygous typing cells. Tissue Antigens 1982;19(3):189-197.

(205) AMAR A, OKSENBERG J, COHEN N, COHEN I, BRAUTBAR C. HLA‐D locus in Israel. Characterization of 14 local HTC's and a population study. Tissue Antigens 1982;20(3):198-207.

(206) Kodo H, Brautbar C, Colvin M, Gale RP, Bonavida B. Selective inhibitory effects of 4-hydroperoxycyclophosphamide (4-HCY) on T and B functions in man. Int J Immunopharmacol 1982;4(4):366.

(207) Hacham‐Zadeh S, Brautbar C, Cohen CA, Cohen T. HLA and alopecia areata in Jerusalem. Tissue Antigens 1981;18(1):71-74.

(208) Brautbar C, Freier S, Ashkenazi A, Dekelbaum R, Tur‐Kaspa I, Amar A, et al. Histocompatibility Determinants in Israeli Jewish Patients with Coeliac Disease: Population and Family Study. Tissue Antigens 1981;17(3):313-322.

(209) Brautbar C, Theodor R, Sack J, Levene C, Dupont B, Levine LS, et al. HLA in a Selective Aldosterone Biosynthetic Defect due to Type 2 Corticosterone Methyl‐Oxidase Deficiency. Tissue Antigens 1981;17(2):212-216.

(210) Brautbar C, Cohen T, Nelken D. Disputed Parentage Due to Exchanged Babies Solved by HLA. Vox Sang 1980;39(6):322-326.

(211) Cohen T, Levene C, Yodfat Y, Fidel J, Friedlander Y, Steinberg AG, et al. Genetic studies on Cochin Jews in Israel: 1. Population data, blood groups, isoenzymes, and HLA determinants. Am J Med Genet 1980;6(1):61-73.

(212) Rosenmann A, Schumert Z, Theodor R, Cohen T, Brautbar C. Amniotic 17-α hydroxyprogesterone and HLA typing for the prenatal diagnosis of 21-α hydroxylase deficiency - congenital adrenal hyperplasia. Am J Med Genet 1980;6(4):295-300.

(213) Steinberg AG, Levene C, Yodfat Y, Fidel J, Brautbar C, Cohen T. Genetic studies on Cochin Jews in Israel: 2. Gm and Inv Data - polymorphism for Gm3 and for Gm1,17,21 without Gm(26). Am J Med Genet 1980;6(1):75-81.

(214) Brautbar C, Moscovitz M, Livshits T, Haim S, Hacham‐Zadeh S, Cohen HA, et al. HLA–DRw4 in Pemphigus Vulgaris Patients in Israel. Tissue Antigens 1980;16(3):238-243.

(215) Brautbar C, Rösler A, Landau H, Cohen I, Nelken D, Cohen T, et al. No Linkage between HLA and Congenital Adrenal Hyperplasia Due to 11-β-Hydroxylase Deficiency. New Engl J Med 1979;300(4):205-206.

(216) Ticho U, Cohen T, Brautbar C. Absence of association between HLA antigens and primary open angle glaucoma in Israel. Isr J Med Sci 1979;15(2):124-127.

(217) Gazit E, Brautbar C, Efter T, Cohen R, Yehoshua H, Zamir R. HLA Polymorphism in Israel*: 1. Jews of Polish Extraction. Tissue Antigens 1978;11(3):195-200.

(218) Zamir R, Brautbar C, Mizrachi Y, Yehoshua H, Gazit E. HLA Polymorphism in Israel: 4. Israeli Jews originating from Rumania. Tissue Antigens 1978;11(3):213-216.

(219) Brautbar C, Chajek T, Ben‐Tuvia S, Lamm L, Cohen T. A Genetic Study of Behqet Disease in Israel. Tissue Antigens 1978;11(2):113-120.

(220) Gazit E, Brautbar C, Mizrachi Y, Cohen R, Yehoshua H, Zamir R. HLA Polymorphism in Israel: 7. The Babylonian Jews. Tissue Antigens 1978;11(3):226-229.

(221) Brautbar C, Zamir R, Efter T, Gazit E. HLA Polymorphism in Israel: 2. Israeli Jews originating from Russia. Tissue Antigens 1978;11(3):201-205.

(222) Bonné‐Tamir B, Bodmer JG, Bodmer WF, Pickbourne P, Brautbar C, Gazit E, et al. HLA Polymorphism in Israel: 9. An Overall Comparative Analysis. Tissue Antigens 1978;11(3):235-250.

(223) Gazit E, Zamir R, Efter T, Zfat Z, Brautbar C. HLA Polymorphism in Israel: 5. The Moroccan Jews. Tissue Antigens 1978;11(3):217-220.

(224) Brautbar C, Lahana E, Alter M, Jørgensen F, Lamm L. Lack of Association between HLA-DW2 and Multiple Sclerosis in Israeli Jewish Patients. New Engl J Med 1977;296(26):1537-1538.

(225) Brautbar C, Cohen I, Kahana E, Alter M, Jørgensen F, Lamm L. Histocompatibility Determinants in Israeli Jewish Patients with Multiple Sclerosis. Tissue Antigens 1977;10(4):291-302.

(226) Galili U, Brautbar C, Schlesinger M. Association between HLA Determinants and Complement Receptors on Human Lymphocytes. Tissue Antigens 1977;10(2):99-107.

(227) Brautbar C, Porat S, Nelken D, Gabriel KR, Cohen T. HLA B27 and ankylosing spondylitis in the Israeli population. J Rheumatol Suppl 1977;3:24-32.

(228) Bentwich R, Cohen R, Brautbar C. T and B blocking factors in Hodgkin's disease. Adv Exp Med Biol 1976;66:685-690.

(229) Bentwich Z, Cohen R, Brautbar C. Proceedings: T and B blocking factors in Hodgkin's disease. Isr J Med Sci 1975;11(12):1382.

(230) Brautbar C, Nelken D, Boss JH, Superstine E. Autoimmune graft rejection. II. Rejection of skin autotransplants in rats sensitized with homologous and heterologous skin preparations. Int Arch Allergy Appl Immunol 1970;39(1):98-104.

(231) Nelken D, Brautbar C, Boss JH. Autograft rejection, temporary transplantation of autografts to allogeneic and xenogeneic hosts within and without diffusion chambers. Experientia 1969;25(10):1080.

(232) Brautbar C, Nelken D, Boss JH. Autograft rejection: I. Effect of prior transplantation to allogeneic and xenogeneic hosts. Transplantation 1969;8(2):121-126.

(233) Brautbar C, Nelken D, Boss JH. Autoimmune graft rejection. Int Arch Allergy Immunol 1969;35(4):323-329.

(234) Brautbar C, Nelken D. Accelerated rejection of rat allografts after the rejection of rabbit skin grafts. Clin Exp Immunol 1967;2(6):691-695.

(235) Brautbar C, Nelken D. Shortened survival of rat allografts after the rejection of xenografts. Isr J Med Sci 1967;3(4):580-581.